Time to buy diagnostic stocks? This is what Hemang Jani has to say

October 24, 2024

Hemang Jani highlights the stability of diagnostic stocks like Dr Lal PathLabs. He also talks about the midcap stocks’ stability and performance despite high debt. Metro Brands and VIP Industries have been underperforming despite a tourism boom. He cautions against Hyundai due to slow growth but sees potential in future market corrections.

More To Explore

Tech View: Nifty forms doji candle; buy-on-dips suggested with 22,780 as key support. How to trade on Thursday

Tech view: Nifty has formed a double bottom pattern and a doji candle near key support levels. The 21-day simple moving average (DSMA) at 23,285

February 12, 2025

ITC Hotels shares may rally by 30% led by strong franchise: Jefferies

ITC Hotels: Jefferies initiated coverage on ITC Hotels (ITCH) with a ‘buy’ rating and a target price of Rs 240, citing strong growth potential. It

February 12, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003